– UK, London – HSBC Holdings plc (LON: HSBA) today announced the appointment of Kalpana Morparia to its Board as an Independent Non-Executive Director with effect from 1 March 2023, bringing extensive Asian business and cultural experience, gained over a 45-year career in banking in the region, primarily in India.
“Kalpana is a very experienced banker, with gravitas and presence. Her deep banking expertise and experience of the Asia region, particularly in India and Southeast Asia, will be an asset to the Board as we focus on growth in those markets under our Pivot to Asia strategy. We are delighted to welcome her to the HSBC Board.” said Board Chair, Mark Tucker.
Kalpana will also join the Group Risk Committee and the Nomination and Corporate Governance Committee.
About Kalpana Morparia
Her most recent executive role was as Chair of J.P. Morgan, South, and Southeast Asia, and a member of JPMorgan’s Asia executive committee, which she held until her retirement in 2021.
Before joining J.P. Morgan, Kalpana Morparia served as Joint Managing Director of ICICI Bank, India’s second-largest bank, from 2001 to 2007. She currently serves as an independent non-executive on the boards of Hindustan Unilever Limited, Dr.Reddy’s Laboratories Limited., and Philip Morris International Inc.
About HSBC Group
HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 63 countries and territories in its geographical regions: Europe, Asia, North America, Latin America, and the Middle East and North Africa. With assets of US$2,992bn on 30 September 2022, HSBC is one of the world’s largest banking and financial services organizations.
For more information: https://www.hsbc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.